Opportunites for Clinical Applications using MSC stem cells are multiple.  We are investigating in clinical applications, such as immunosuppression effects for tissue grafts and cell transplants, tissue engineering and ...
Our biggest differentiator is the fact that we use 'autologous' stem cells and induce them in an 'in vivo' environment, reducing the need for Biobanking. Our technology appears to be :

• cheaper than current existing stem cells inducing technologies
• strongly lowering rejection risks and other negative side effects recently noticed after using allogenic stemcells and/or in vitro cultivation.
• resulting in much better quality stem cells
• having shorter throughput times during induction